Orthofix (OFIX) President Patrick Fisher Sells 150 Shares

What Happened
Patrick Fisher, President, Global Limb Reconstruction at Orthofix Medical, sold 150 shares of OFIX stock in an open‑market transaction on September 1, 2026. The shares were sold at $9.39 per share for a total proceeds of approximately $1,409. This was a sale (not a purchase); sales are often routine and do not necessarily indicate a change in insider view.

Key Details

• Transaction date and price: 2026-09-01 — 150 shares sold at $9.39 each (total ~$1,409).
• Method: Open market sale reported on Form 4.
• Shares owned after transaction: Not specified in this filing; filing notes include 36,028 previously reported restricted stock units.
• Footnotes: Sale was effected pursuant to a Rule 10b5‑1 trading plan adopted by Fisher on May 29, 2026.
• Filing timeliness: Form filed 2026-09-03 for a 2026-09-01 transaction — appears timely (Form 4s are generally due within two business days).

Context
Because the sale was executed under a pre-established 10b5‑1 plan, it was likely an automated/trading‑plan transaction rather than a discretionary trade made that day. For retail investors, single small sales like this (150 shares, ~$1.4K) are typically routine and less informative than insider purchases, larger sales, or transactions by 10% owners.